Cargando…
Utility of fractional exhaled nitric oxide suppression as a prediction tool for progression to biologic therapy
RATIONALE: The utility of fractional exhaled nitric oxide (F(ENO)) suppression (FeNOSuppT) to identify non-adherence to inhaled corticosteroid (ICS) treatment has previously been reported, but whether it can predict clinical outcome remains unclear. OBJECTIVES: We examined the utility of FeNOSuppT i...
Autores principales: | Butler, Claire A., McMichael, Alan J., Honeyford, Kirsty, Wright, Louise, Logan, Jayne, Holmes, Joshua, Busby, John, Hanratty, Catherine E., Yang, Freda, Smith, Steven J., Murray, Kirsty, Chaudhuri, Rekha, Heaney, Liam G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450452/ https://www.ncbi.nlm.nih.gov/pubmed/34549044 http://dx.doi.org/10.1183/23120541.00273-2021 |
Ejemplares similares
-
Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma
por: Couillard, Simon, et al.
Publicado: (2021) -
Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD
por: Turner, Steve W., et al.
Publicado: (2019) -
Glucocorticoid toxicity reduction with mepolizumab using the Glucocorticoid Toxicity Index
por: McDowell, P. Jane, et al.
Publicado: (2022) -
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma
por: Buendía, Jefferson Antonio, et al.
Publicado: (2021) -
Measurement of Fractional Exhaled Nitric Oxide in Stable Bronchiectasis
por: Cho, Young-Jae, et al.
Publicado: (2013)